Promising Live Chikungunya Vaccine Shows 98.9% Protection in Human Trial
A recent Phase III human trial has revealed a live chikungunya vaccine to be highly protective, offering a potential solution to the rising global spread of mosquito-borne illnesses associated with climate change. The vaccine, administered…